3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
21
Prostatic Neoplasms
11
Neoplasms
8
Head and Neck Neoplasms
8
Ovarian Neoplasms
6
Oropharyngeal Neoplasms
4
Lung Neoplasms
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Sarcoma
3
Rectal Neoplasms
3
Polycystic Ovary Syndrome
3
Pancreatic Neoplasms
3
Hematologic Neoplasms
3
Endometrial Neoplasms
3
Carcinoma, Squamous Cell
3
Carcinoma, Renal Cell
3
Brain Neoplasms
3
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Psychological Well-Being
2
Motor Activity
2
Melanoma
2
Kidney Neoplasms
2
Gastrointestinal Neoplasms
2
Esophageal Neoplasms
2
Communication
2
Colonic Neoplasms
2
Central Nervous System Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Interventions
pembrolizumab
2
durvalumab
2
Paclitaxel
2
Nivolumab
2
Ipilimumab
2
Doxorubicin
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
trebananib
1
trastuzumab duocarmazine
1
talazoparib
1
spartalizumab
1
selinexor
1
sarilumab
1
pexidartinib
1
pertuzumab
1
pazopanib
1
patritumab
1
olaparib
1
niraparib
1
neratinib
1
ganitumab
1
dostarlimab
1
cemiplimab
1
balstilimab
1
abemaciclib
1
Trastuzumab
1
Standard of Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hemangiosarcoma
×
Surveys and Questionnaires
×
90 days
×
Clear all
No trials found.